Angst Felix, Goldhahn Jörg, Drerup Susann, Aeschlimann André, Schwyzer Hans-Kaspar, Simmen Beat R
Schulthess Klinik, Zurich, Switzerland.
Arthritis Rheum. 2008 Mar 15;59(3):391-8. doi: 10.1002/art.23318.
To assess the responsiveness (sensitivity to change) of 6 shoulder outcome instruments.
In a prospective cohort study of 153 total shoulder arthroplasties, outcome was measured by the Short Form 36 (SF-36); Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH); Shoulder Pain and Disability Index (SPADI); American Shoulder and Elbow Surgeons questionnaire for the shoulder (ASES); and the Constant (Murley) Score (CS). Responsiveness was mainly quantified by effect sizes before and 6 months after operation. Sensitivity analysis of the effects by receiver operating characteristic (ROC) curves was performed to determine the instruments' ability to classify effects into global health change assessment categories.
Effect sizes of the self-assessment total scores were 0.71, 1.19, 2.10, and 2.13 for the SF-36, DASH, SPADI, and ASES, respectively. The clinical ASES and the CS had effect sizes of 1.87 and 2.23, respectively. The SPADI (effect size 2.12) and the CS (effect size 2.72) were most responsive for pain. For functioning, the patient ASES (effect size 2.10), the CS (effect size 1.82), and the clinical ASES (effect size 1.85) were almost equal. The SF-36 bodily pain scale and most scores of the condition-specific instruments showed a significant area under the ROC of up to 0.77.
The SPADI and/or the CS are the most suitable for short, responsive, shoulder-specific assessment. The more expensive patient ASES can be used for most responsive shoulder-function assessment. For a comprehensive measurement of health and quality of life, the DASH and/or the SF-36 should be added to the set.
评估6种肩部结局评估工具的反应性(对变化的敏感性)。
在一项对153例全肩关节置换术的前瞻性队列研究中,采用简短健康调查问卷36项简表(SF-36)、手臂、肩部和手部功能障碍问卷(DASH)、肩部疼痛和功能障碍指数(SPADI)、美国肩肘外科医师协会肩部问卷(ASES)以及Constant(Murley)评分(CS)来测量结局。反应性主要通过手术前和术后6个月的效应量进行量化。通过受试者工作特征(ROC)曲线对效应进行敏感性分析,以确定这些评估工具将效应分类到整体健康变化评估类别的能力。
SF-36、DASH、SPADI和ASES自我评估总分的效应量分别为0.71、1.19、2.10和2.13。临床ASES和CS的效应量分别为1.87和2.23。SPADI(效应量2.12)和CS(效应量2.72)对疼痛的反应性最强。对于功能方面,患者ASES(效应量2.10)、CS(效应量1.82)和临床ASES(效应量1.85)几乎相同。SF-36身体疼痛量表以及大多数特定病情评估工具的评分在ROC曲线下的面积高达0.77,具有显著意义。
SPADI和/或CS最适合用于简短、反应性强的肩部特异性评估。更昂贵的患者ASES可用于反应性最强的肩部功能评估。为全面测量健康和生活质量,应在评估组合中加入DASH和/或SF-36。